Mobile

You are not alone!

Tomorrow’s MET-Positive Lung Cancer Treatment Today

Get ahead of standard treatments for MET-positive lung cancer. Participating in a clinical trial for MET-positive lung cancer gives you access to the latest therapies.

Call +1 844 627 7246

    Find treatment options now

    A Patient Advocate will reach out to you in less than 24 hours.


    Your personal data is fully confidential and 100% secure

      Find treatment options now

      A Patient Advocate will reach out to you in less than 24 hours.


      Your personal data is fully confidential and 100% secure

      Understanding Your Options for Treating MET-Positive Lung Cancer

      If your doctor has told you that your lung cancer is MET-positive, it means that you either have too many copies of the MET gene (which is relatively unusual) or that gene has a DNA error called MET exon 14 skipping (which is more common). If you have this MET exon 14 error, cells can’t get rid of growth-promoting MET proteins in an orderly way, which causes them to fuel the spread of cancer.  

      met biomarker cancermet biomarker cancer

      Having this MET mutation is associated with lung cancer that’s challenging to treat. However, several new drugs that target the MET gene alteration are now available. And new therapies that work by addressing problems caused by having too many copies of MET and MET exon 14 skipping are being studied in clinical trials.   

       

      What Are Clinical Trials? 

      A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.  

      Why Massive Bio?
      Our AI matching tool makes cancer treatment simple.

      We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.

      Access the free matching tool

      How Massive Bio Helps Patients With MET-Positive Lung Cancer

      Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of new therapies. If you aren’t sure if your lung cancer is MET-positive, that’s okay. Additional testing can help determine your exact diagnosis. 

      Hear from our Co founder & CEO

      Selin Kurnaz on how she struggled to find the right treatment for her uncle and started Massive Bio to help others.

      There is a major gap between what pharmaceutical companies are working on right now vs. what cancer patients are getting. Massive Bio is revolutionizing this process.
      Selin Kurnaz, Co-Founder, CEO
      People's stories
      Star Star Star Star Star

      “Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“

      Mylan Tran
      Cancer Patient Caregiver
      Google Reviews
      You are in good hands

      Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.

      Call +1 844 627 7246
      Cancer Clinical Trials Patients Cancer Clinical Trials Patients

      What is a HER2-Positive Cancer clinical trial?

      Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.

      Cancer Ribbon
      About Massive Bio

      At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.